DPEP2 and myocarditis: This inspired us that abundant macrophage Dpep2 at the early stage of VMC might be important for controlling massive cardiac inflammation, and ensuring competent Dpep2 in macrophages might represent a novel therapeutic strategy against CVB3-induced myocarditis.